Clinical Trials Tracker

Ketalux Clinical Trials Tracker: Ketamine & Esketamine Studies

Registered studies are the earliest public signal of where ketamine research is heading. These listings come straight from the U.S. registry — Ketalux does not edit, rank, or summarize study results here.

Written by: Ira ZootMedical review status: Pending clinical reviewLast updated: August 24, 2026Evidence: ClinicalTrials.gov registry data

Quick answer

Does appearing in a clinical trial mean a treatment works?

No. Registration means a study has been planned and listed with a public registry. It says nothing about whether the intervention is safe or effective for the condition being studied — those conclusions require completed, peer-reviewed results.

InterventionRecruitment statusStudy phaseCondition

Loading registry data…

How to read a trial listing

Phase matters: Phase 1 studies test safety in small groups, Phase 2 looks for early signals of effect, and Phase 3 tests effectiveness against a comparator at scale. Recruitment status tells you whether enrollment is open, not whether the study has produced results. For published results, see the Research Library; for regulatory context, see the Regulatory Tracker.

About the author

Ira Zoot

Independent publisher and editor of Ketalux, based in Chicago, Illinois. Ira commissions, edits, and reviews every article on the site and believes ketamine therapy — used responsibly — offers real hope for people living with depression, anxiety, PTSD, and chronic pain. Contact: ira@idigits.com.

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.